Gates backs development work on a long-acting contraceptive pill
The risk of pregnancy is much lower for women who take their oral contraceptive pill correctly — every day at about the same time. In the United States, the pills are not available over the counter, and these factors contribute to poor medication adherence, and in turn, unwanted pregnancies. Lyndra Therapeutics is working on the fix — a pill that can be taken weekly, or even monthly.
In its quest, the Watertown, Massachusetts-based drug developer has scored a $13 million grant from the Bill & Melinda Gates Foundation.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.